Skip to content

Abbott Laboratories

NYSE: ABT · USD

Abbott Laboratories cash flow and EPS82

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$4,049M
Abbott Laboratories capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q218.77% · $262.74M1.24% · $17.332M0.13% · $1.828M44.16% · $618.227M35.71% · $500M100% · $1,400.127M
FY 2009 Q334.34% · $328.71M0.99% · $9.512M0.06% · $0.605M64.6% · $618.376M0% · $0M100% · $957.203M
FY 2009 Q414.3% · $245.447M49.61% · $851.727M0.06% · $0.959M36.04% · $618.776M0% · $0M100% · $1,716.909M
FY 2010 Q13.01% · $245.143M78.78% · $6,415.648M10.58% · $861.368M7.62% · $620.752M0.02% · $1.254M100% · $8,144.165M
FY 2010 Q218.74% · $273.514M34.56% · $504.395M0.17% · $2.479M46.53% · $679.199M0% · $0M100% · $1,459.587M
FY 2010 Q36.64% · $205.085M71.27% · $2,200M0.08% · $2.326M22.01% · $679.423M0% · $0M100% · $3,086.834M
FY 2010 Q49.81% · $291.333M10.55% · $313.2M0.02% · $0.652M23.3% · $692.101M56.32% · $1,672.744M100% · $2,970.03M
FY 2011 Q123.77% · $391.813MUnavailable4.35% · $71.75M41.5% · $683.967M30.37% · $500.582M100% · $1,648.112M
FY 2011 Q214.17% · $372.957MUnavailable0.08% · $2.095M28.52% · $750.409M57.23% · $1,506.097M100% · $2,631.558M
FY 2011 Q326.72% · $451.995M28.68% · $485M0.03% · $0.583M44.44% · $751.63M0.13% · $2.157M100% · $1,691.365M
FY 2011 Q413.51% · $274.735M0% · $0M0.13% · $2.579M36.99% · $752.09M49.37% · $1,003.59M100% · $2,032.994M
FY 2012 Q115.5% · $453.33M22.94% · $670.849M33.77% · $987.686M25.94% · $758.548M1.85% · $54M100% · $2,924.413M
FY 2012 Q220.47% · $425.116M5.3% · $110M35.37% · $734.428M38.86% · $806.984M0% · $0M100% · $2,076.528M
FY 2012 Q330.17% · $530.747M23.97% · $421.624M0.07% · $1.234M45.79% · $805.405M0% · $0M100% · $1,759.01M
FY 2012 Q43% · $386.096M0.19% · $25M4.98% · $640.892M6.3% · $811.874M85.53% · $11,017.178M100% · $12,881.04M
FY 2013 Q119.28% · $274.465MUnavailable65.01% · $925.333M15.71% · $223.561MUnavailable100% · $1,423.359M
FY 2013 Q236.27% · $290.419MUnavailable36.19% · $289.818M27.54% · $220.536MUnavailable100% · $800.773M
FY 2013 Q332.63% · $276.457MUnavailable41.43% · $351.008M25.93% · $219.687MUnavailable100% · $847.152M
FY 2013 Q452.86% · $303.659M2.39% · $13.729M6.76% · $38.841M37.99% · $218.216MUnavailable100% · $574.445M
FY 2014 Q19.14% · $255MUnavailable78.57% · $2,192M12.29% · $343MUnavailable100% · $2,790M
FY 2014 Q243.58% · $258MUnavailable0.17% · $1M56.25% · $333MUnavailable100% · $592M
FY 2014 Q345.48% · $277MUnavailable0.16% · $1M54.35% · $331MUnavailable100% · $609M
FY 2014 Q425.67% · $287M44.28% · $495M0.09% · $1M29.96% · $335MUnavailable100% · $1,118M
FY 2015 Q112.02% · $235MUnavailable68.85% · $1,346M18.62% · $364M0.51% · $10M100% · $1,955M
FY 2015 Q236% · $216MUnavailable0.17% · $1M60% · $360M3.83% · $23M100% · $600M
FY 2015 Q340.85% · $411M22.96% · $231M0.2% · $2M35.69% · $359M0.3% · $3M100% · $1,006M
FY 2015 Q416.35% · $248M0% · $0M58.54% · $888M23.73% · $360M1.38% · $21M100% · $1,517M
FY 2016 Q121.06% · $243MUnavailable44.97% · $519M33.36% · $385M0.61% · $7M100% · $1,154M
FY 2016 Q238.9% · $247MUnavailable0.16% · $1M60.47% · $384M0.47% · $3M100% · $635M
FY 2016 Q340.78% · $312M8.63% · $66M0.26% · $2M50.2% · $384M0.13% · $1M100% · $765M
FY 2016 Q444.74% · $319M0.98% · $7M0% · $0M54.14% · $386M0.14% · $1M100% · $713M
FY 2017 Q11.66% · $272M79.63% · $13,027M0.58% · $95M2.81% · $460M15.31% · $2,505M100% · $16,359M
FY 2017 Q235.32% · $255M0% · $0M0.42% · $3M63.99% · $462M0.28% · $2M100% · $722M
FY 2017 Q335.78% · $263M0% · $0M1.09% · $8M62.99% · $463M0.14% · $1M100% · $735M
FY 2017 Q43.1% · $345M37.38% · $4,156M0.1% · $11M4.17% · $464M55.24% · $6,142M100% · $11,118M
FY 2018 Q13.99% · $275M0.36% · $25M1.86% · $128M7.12% · $491M86.68% · $5,979M100% · $6,898M
FY 2018 Q214.1% · $298M0.85% · $18M0.14% · $3M23.37% · $494M61.54% · $1,301M100% · $2,114M
FY 2018 Q319.14% · $354MUnavailable0.16% · $3M26.7% · $494M54% · $999M100% · $1,850M
FY 2018 Q48.95% · $467MUnavailable1.99% · $104M9.48% · $495M79.58% · $4,154M100% · $5,220M
FY 2019 Q119.76% · $335M4.6% · $78M12.8% · $217M33.33% · $565M29.5% · $500M100% · $1,695M
FY 2019 Q240.94% · $468M7.17% · $82M0.35% · $4M49.69% · $568M1.84% · $21M100% · $1,143M
FY 2019 Q341.21% · $401MUnavailable0.1% · $1M58.48% · $569M0.21% · $2M100% · $973M
FY 2019 Q49.83% · $434MUnavailable11.23% · $496M12.86% · $568M66.08% · $2,918M100% · $4,416M
FY 2020 Q129.15% · $360MUnavailable19.11% · $236M51.66% · $638M0.08% · $1M100% · $1,235M
FY 2020 Q249.81% · $642MUnavailable0.31% · $4M49.81% · $642M0.08% · $1M100% · $1,289M
FY 2020 Q320.11% · $496MUnavailable0.08% · $2M25.9% · $639M53.91% · $1,330M100% · $2,467M
FY 2020 Q445.82% · $679MUnavailable10.86% · $161M43.25% · $641M0.07% · $1M100% · $1,482M
FY 2021 Q126.93% · $397MUnavailable18.66% · $275M54.27% · $800M0.14% · $2M100% · $1,474M
FY 2021 Q224.44% · $413MUnavailable27.87% · $471M47.51% · $803M0.18% · $3M100% · $1,690M
FY 2021 Q324.51% · $461MUnavailable30.78% · $579M42.58% · $801M2.13% · $40M100% · $1,881M
FY 2021 Q425.7% · $614MUnavailable40.77% · $974M33.4% · $798M0.13% · $3M100% · $2,389M
FY 2022 Q17.62% · $321MUnavailable54.79% · $2,307M19.76% · $832M17.83% · $751M100% · $4,211M
FY 2022 Q231.24% · $379MUnavailable0.41% · $5M68.26% · $828M0.08% · $1M100% · $1,213M
FY 2022 Q322.32% · $467MUnavailable38.15% · $798M39.48% · $826M0.05% · $1M100% · $2,092M
FY 2022 Q428.8% · $610MUnavailable32.34% · $685M38.86% · $823MUnavailable100% · $2,118M
FY 2023 Q120.99% · $380MUnavailable29.83% · $540M49.17% · $890M0% · $0M100% · $1,810M
FY 2023 Q227.78% · $507MUnavailable23.34% · $426M48.77% · $890M0.11% · $2M100% · $1,825M
FY 2023 Q319.34% · $560MUnavailable0.07% · $2M30.67% · $888M49.91% · $1,445M100% · $2,895M
FY 2023 Q439.7% · $755MUnavailable13.62% · $259M46.69% · $888MUnavailable100% · $1,902M
FY 2024 Q125.17% · $398MUnavailable14.29% · $226M60.53% · $957M0% · $0M100% · $1,581M
FY 2024 Q235.18% · $533MUnavailable0.2% · $3M63.43% · $961M1.19% · $18M100% · $1,515M
FY 2024 Q324.5% · $556MUnavailable33.1% · $751M42.31% · $960M0.09% · $2M100% · $2,269M
FY 2024 Q436.13% · $720MUnavailable15.81% · $315M48.07% · $958MUnavailable100% · $1,993M
FY 2025 Q117.34% · $484MUnavailable10.03% · $280M36.76% · $1,026M35.87% · $1,001M100% · $2,791M
FY 2025 Q232.64% · $502MUnavailable0.39% · $6M66.91% · $1,029M0.07% · $1M100% · $1,538M
FY 2025 Q321.26% · $496MUnavailable13.07% · $305M44.19% · $1,031M21.47% · $501M100% · $2,333M
FY 2025 Q434.09% · $689MUnavailable14.94% · $302M50.96% · $1,030MUnavailable100% · $2,021M
FY 2026 Q112.9% · $399MUnavailable5.82% · $180M35.5% · $1,098M45.78% · $1,416M100% · $3,093M
FY 2026 Q212.27% · $497MUnavailable25.81% · $1,045M27.22% · $1,102M34.7% · $1,405M100% · $4,049M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$2,488M

Capital expenditures

USD millions

$497M

Free cash flow

USD millions

$1,991M

Stock-based compensation

USD millions

$168M

SBC / free cash flow

% · FCF before SBC deduction

8.44%

SBC / operating cash flow

%

6.75%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$0.53

Quarterly data

Abbott Laboratories cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20262,4884971,9911688.44%6.75%—$0.53
FY 2026 Q1Mar 31, 20261,31539991631734.61%24.11%—$0.61
FY 2025 Q4Dec 31, 20253,3156892,6261134.3%3.41%——
FY 2025 Q3Sep 30, 20252,7874962,2911205.24%4.31%—$0.94
FY 2025 Q2Jun 30, 20252,0475021,5451429.19%6.94%—$1.01
FY 2025 Q1Mar 31, 20251,41748493328930.98%20.4%—$0.76
FY 2024 Q4Dec 31, 20242,8687202,1481115.17%3.87%——
FY 2024 Q3Sep 30, 20242,7055562,1491175.44%4.33%—$0.94
FY 2024 Q2Jun 30, 20241,9605331,4271419.88%7.19%—$0.74
FY 2024 Q1Mar 31, 20241,02539862730448.48%29.66%—$0.7
FY 2023 Q4Dec 31, 20233,0387552,2831144.99%3.75%——
FY 2023 Q3Sep 30, 20231,8775601,3171178.88%6.23%—$0.82
FY 2023 Q2Jun 30, 20231,20350769613218.97%10.97%—$0.78
FY 2023 Q1Mar 31, 20231,14338076328136.83%24.58%—$0.75
FY 2022 Q4Dec 31, 20222,3266101,7161156.7%4.94%——
FY 2022 Q3Sep 30, 20222,7804672,3131235.32%4.42%—$0.81
FY 2022 Q2Jun 30, 20222,4103792,0311426.99%5.89%—$1.14
FY 2022 Q1Mar 31, 20222,0653211,74430517.49%14.77%—$1.37
FY 2021 Q4Dec 31, 20213,0676142,4531064.32%3.46%——
FY 2021 Q3Sep 30, 20212,7014612,2401145.09%4.22%—$1.17
FY 2021 Q2Jun 30, 20212,1284131,7151327.7%6.2%—$0.66
FY 2021 Q1Mar 31, 20212,6373972,24028812.86%10.92%—$1
FY 2020 Q4Dec 31, 20203,7986793,119983.14%2.58%——
FY 2020 Q3Sep 30, 20202,0664961,5701006.37%4.84%—$0.69
FY 2020 Q2Jun 30, 20201,32264268011516.91%8.7%—$0.3
FY 2020 Q1Mar 31, 202071536035523365.63%32.59%—$0.31
FY 2019 Q4Dec 31, 20192,4164341,982854.29%3.52%—$0.59
FY 2019 Q3Sep 30, 20191,9484011,547946.08%4.83%—$0.53
FY 2019 Q2Jun 30, 20191,06046859211419.26%10.75%—$0.56
FY 2019 Q1Mar 31, 201971233537722659.95%31.74%—$0.38
FY 2018 Q4Dec 31, 20181,7654671,298816.24%4.59%—$0.37
FY 2018 Q3Sep 30, 20182,1833541,829834.54%3.8%—$0.32
FY 2018 Q2Jun 30, 20181,24429894610110.68%8.12%—$0.41
FY 2018 Q1Mar 31, 20181,10827583321225.45%19.13%—$0.23
FY 2017 Q4Dec 31, 20171,6403451,295685.25%4.15%—$-0.48
FY 2017 Q3Sep 30, 20172,0052631,742754.31%3.74%—$0.34
FY 2017 Q2Jun 30, 20171,3512551,096928.39%6.81%—$0.16
FY 2017 Q1Mar 31, 201757427230217156.62%29.79%—$0.24
FY 2016 Q4Dec 31, 20161,170319851475.52%4.02%—$0.53
FY 2016 Q3Sep 30, 20161,217312905495.41%4.03%—$-0.22
FY 2016 Q2Jun 30, 2016909247662629.37%6.82%—$0.41
FY 2016 Q1Mar 31, 2016-93243-336152———$0.21
FY 2015 Q4Dec 31, 2015828248580437.41%5.19%—$0.51
FY 2015 Q3Sep 30, 20151,195411784445.61%3.68%—$0.38
FY 2015 Q2Jun 30, 2015941216725577.86%6.06%—$0.52
FY 2015 Q1Mar 31, 20152235-233148—7,400%—$1.51
FY 2014 Q4Dec 31, 20141,238287951384%3.07%—$0.59
FY 2014 Q3Sep 30, 20141,201277924404.33%3.33%—$0.36
FY 2014 Q2Jun 30, 2014900258642497.63%5.44%—$0.3
FY 2014 Q1Mar 31, 201433625581119146.91%35.42%—$0.24
FY 2013 Q4Dec 31, 20131,625.06303.661,321.439.953.02%2.46%—$0.37
FY 2013 Q3Sep 30, 2013522.13276.46245.6744.7618.22%8.57%—$0.61
FY 2013 Q2Jun 30, 2013716.56290.42426.1451.5512.1%7.19%—$0.3
FY 2013 Q1Mar 31, 2013460.26274.47185.79125.7567.68%27.32%—$0.34
FY 2012 Q4Dec 31, 20121,503.14386.11,117.0474.386.66%4.95%—$0.66
FY 2012 Q3Sep 30, 20123,519.5530.752,988.7675.612.53%2.15%—$0.58
FY 2012 Q2Jun 30, 20122,066.83425.121,641.7185.795.23%4.15%—$0.52
FY 2012 Q1Mar 31, 20122,224.93453.331,771.6197.3411.14%8.87%—$0.37
FY 2011 Q4Dec 31, 20111,401.35274.741,126.6162.55.55%4.46%—$0.49
FY 2011 Q3Sep 30, 20113,054.434522,602.4467.842.61%2.22%—$0.09
FY 2011 Q2Jun 30, 20112,503.15372.962,130.276.463.59%3.05%—$0.59
FY 2011 Q1Mar 31, 20112,011.15391.811,619.33175.8110.86%8.74%—$0.26
FY 2010 Q4Dec 31, 20102,316.52291.332,025.1956.952.81%2.46%—$0.44
FY 2010 Q3Sep 30, 20102,548.41205.092,343.3372.153.08%2.83%—$0.27
FY 2010 Q2Jun 30, 20102,348.3273.512,074.7884.224.06%3.59%—$0.4
FY 2010 Q1Mar 31, 20101,522.75245.141,277.61173.8713.61%11.42%—$0.31
FY 2009 Q4Dec 31, 2009—245.45—58.86———$0.47
FY 2009 Q3Sep 30, 20093,030.02328.712,701.3162.592.32%2.07%—$0.46
FY 2009 Q2Jun 30, 20091,713.8262.741,451.0657.963.99%3.38%—$0.4
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · ABT, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.